Roos Jutten
@RoosJutten
Followers
894
Following
2K
Statuses
397
PhD, neuropsychologist | Research Fellow @MGHNeurology & @HarvardMed | Alzheimer’s disease, cognition, measurement, remote digital assessment
Boston, MA
Joined October 2018
🔔Our paper in @npjDigitalMed! Assessing learning over days through #remote #digital testing reveals subtle memory differences across individuals with different amyloid and tau biomarker profiles.📱📉🧠 @HarvardAging @BRANCH_Harvard @MGH_RI @BWHNeurology
1
9
29
📣 Neuropsychologists and cognition researchers working on #Alzheimers disease, check out this important survey!
Now accepting responses through 1/15. Fill out the survey using the link below! @INSneuro @TheAACN @ISTAART @APADivision40
0
0
1
🧠 💫 Happening next week (Jan 14th): our @CognitionPia Year in Review webinar, during which we will discus exciting highlights in #cognition and dementia research from 2024, and look ahead to 2025. We look forward to your attendance! Register using the link below. #EndAlz
Happening next week! Register below.
0
1
4
RT @CognitionPia: Register today for the @ISTAART Cognition PIA Year in Review webinar on January 14th at 11:30AM CT.
0
3
0
RT @CognitionPia: The @ISTAART Cognition PIA Year In Review webinar is January 14th at 9AM PST. Register here!
0
2
0
RT @WendyYau01: Excited to share our @FraminghamStudy paper in @ANA_journals!🧠 Sex-specific links between stroke risk factors and subclinic…
0
10
0
🔔👉@CognitionPia members, we need your input! In preparation for our @ISTAART Cognition PIA 2024 Year in Review webinar, please fill out this survey to submit publications & advancements from 2024 that you would like us to highlight. Deadline *Dec 9th*! 🙏
0
2
3
@RikOssenkoppele @_michael_scholl And about screening with remote cognitive testing! Very cool! Looking forward to reading it
0
0
3
What constitutes a clinically meaningful change in everyday functioning for individuals with Alzheimer’s disease, and how can you measure this? 📈🕵️ Sign up for the webinar below! @CognitionPia @ClinTrialsPIA @impact_ad
Really excited to host this upcoming webinar on Friday October 11 where @markdbm will present his work on measuring clinically meaningful change in daily functioning in ADRD. Link to register is below: @DesignDataPIA #Statistics #NeuroTwitter
0
4
16
We are so happy to have you @CeleLopezMoreno!!
This year I have been chosen as a student representative within the Executive Committee of the #cognitionPIA, in @ISTAART. It has been a pleasure to meet the EC during the #AAIC24 I'm excited for everything we can do together!
0
0
4
#AAIC24: what a ride!!🎢 💜 It was so great to learn, present and discuss #Alzheimer's research with so many dear colleagues and friends! 🌎 🙏🏻 Thanks @alzassociation for making this incredible week possible! Time to rest up now. See you in Toronto next year! 😎 #EndAlz
1
0
29
RT @DrTamWatermeyer: Multi-day learning curves (MDLCs) scores diminish ax Biomarker groups, but not uniformly. A+ status regardless of T-st…
0
1
0
RT @IgorCamargoF: Help us help the environment, drop your badge in the recycling box at the end of AAIC 💜
0
9
0
RT @Schultz_SA: I am excited to share our work, out now in @TheLancetNeuro, showing cell-based measures of gamma-secretase activity and amy…
0
16
0
Really enjoyed this fantastic session with excellent presentations by fellow @impact_ad Alumni Scholars! 🙌🏻🌟@AndrewK_PhD @LouisaIsoud
2
1
11
RT @KatherineHack15: I'll be presenting at poster #552 today #AAIC24 comparing the utility of mean vs. intraindividual variability metrics…
0
4
0
It was great to see so many (old and new!) faces at our #AAIC24 @CognitionPia day. 📢 To all PIA members: please attend our business meeting in September to learn more about our goals and activities for next year (keep an eye out for ISTAART emails announcing the date and time).
Thanks for attending the Cognition PIA Day event! We heard exciting new findings from our three lightning talk presenters and introduced our new Executive Committee. There will be more great science at #AAIC24 that we'll highlight this week. @alzassociation @ISTAART
0
1
15
@BaaylaB @GMolenberghs @DrNeuroChic Agreed!! Aso great and very important discussion about the input from study participants in trial design: which is crucial to ensure adherence and retention as well as to measure what matters to the target population.
0
1
3
